Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

732 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Interferon-β is a potent inhibitor of cell growth and cortisol production in vitro and sensitizes human adrenocortical carcinoma cells to mitotane.
van Koetsveld PM, Vitale G, Feelders RA, Waaijers M, Sprij-Mooij DM, de Krijger RR, Speel EJ, Hofland J, Lamberts SW, de Herder WW, Hofland LJ. van Koetsveld PM, et al. Among authors: lamberts sw. Endocr Relat Cancer. 2013 May 30;20(3):443-54. doi: 10.1530/ERC-12-0217. Print 2013 Jun. Endocr Relat Cancer. 2013. PMID: 23507702
The novel somatostatin analog SOM230 is a potent inhibitor of hormone release by growth hormone- and prolactin-secreting pituitary adenomas in vitro.
Hofland LJ, van der Hoek J, van Koetsveld PM, de Herder WW, Waaijers M, Sprij-Mooij D, Bruns C, Weckbecker G, Feelders R, van der Lely AJ, Beckers A, Lamberts SW. Hofland LJ, et al. Among authors: lamberts sw. J Clin Endocrinol Metab. 2004 Apr;89(4):1577-85. doi: 10.1210/jc.2003-031344. J Clin Endocrinol Metab. 2004. PMID: 15070915 Free article.
Potent inhibitory effects of type I interferons on human adrenocortical carcinoma cell growth.
van Koetsveld PM, Vitale G, de Herder WW, Feelders RA, van der Wansem K, Waaijers M, van Eijck CH, Speel EJ, Croze E, van der Lely AJ, Lamberts SW, Hofland LJ. van Koetsveld PM, et al. Among authors: lamberts sw. J Clin Endocrinol Metab. 2006 Nov;91(11):4537-43. doi: 10.1210/jc.2006-0620. Epub 2006 Aug 15. J Clin Endocrinol Metab. 2006. PMID: 16912135
Characterization of the mTOR pathway in human normal adrenal and adrenocortical tumors.
De Martino MC, Feelders RA, de Herder WW, van Koetsveld PM, Dogan F, Janssen JA, Waaijers AM, Pivonello C, Lamberts SW, Colao A, de Krijger RR, Pivonello R, Hofland LJ. De Martino MC, et al. Among authors: lamberts sw. Endocr Relat Cancer. 2014 Aug;21(4):601-13. doi: 10.1530/ERC-13-0112. Epub 2014 Jun 2. Endocr Relat Cancer. 2014. PMID: 24891456
Effects of Somatostatin Analogs and Dopamine Agonists on Insulin-Like Growth Factor 2-Induced Insulin Receptor Isoform A Activation by Gastroenteropancreatic Neuroendocrine Tumor Cells.
van Adrichem RC, de Herder WW, Kamp K, Brugts MP, de Krijger RR, Sprij-Mooij DM, Lamberts SW, van Koetsveld PM, Janssen JA, Hofland LJ. van Adrichem RC, et al. Among authors: lamberts sw. Neuroendocrinology. 2016;103(6):815-25. doi: 10.1159/000444280. Epub 2016 Feb 2. Neuroendocrinology. 2016. PMID: 26836610 Free article.
732 results